Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 73341 record(s)

Req # A-2019-001540

Adverse Reaction Report (AER). Report number: 000725002.

Organization: Health Canada

7 page(s)
February 2020

Req # A-2019-001541

Adverse Reaction Report (AER). Report number: E2B_02465047.

Organization: Health Canada

14 page(s)
February 2020

Req # A-2019-001546

Adverse Reaction Report (AER) for botulinum toxin type A. Report number: E2B_02750326.

Organization: Health Canada

7 page(s)
February 2020

Req # A-2019-001555

Adverse Reaction Report (AER). Report number: E2B_02126749.

Organization: Health Canada

69 page(s)
February 2020

Req # A-2019-001591

Adverse Reaction Report (AER). Report numbers: 000722888, E2B_02353258, 000725859, 000726845, E2B_02675074, E2B_02152615, 000719659, 000721365, E2B_02176698, 000721705, E2B_01920643, E2B_02336054, E2B_01716190, E2B_02306895, E2B_02508710,…

Organization: Health Canada

187 page(s)
February 2020

Req # A-2019-001597

Adverse Reaction Report (AER) for VEDOLIZUMAB. Report numbers: E2B_02729947, E2B_02738885, E2B_02742866, E2B_02744525, E2B_02757854, E2B_02758145, E2B_02758821, E2B_02762247, E2B_02762651.

Organization: Health Canada

212 page(s)
February 2020

Req # A-2019-001603

Adverse Reaction Report (AER) for TECTA. Report numbers: 000729054, 000729232.

Organization: Health Canada

13 page(s)
February 2020

Req # A-2019-001604

Adverse Reaction Report (AER) for PANTOPRAZOLE MAGNESIUM. Report numbers: E2B_02737965, E2B_02742867, E2B_02742869, E2B_02764675.

Organization: Health Canada

176 page(s)
February 2020

Req # A-2019-001608

Adverse Reaction Report (AER). Report number: E2B_02752874.

Organization: Health Canada

42 page(s)
February 2020

Req # A-2019-001610

Adverse Reaction Report (AER). Report number: E2B_02325691.

Organization: Health Canada

10 page(s)
February 2020
Date modified: